☰

Ann Richmond - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

152 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bullock K, Richmond A. Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy. Cancers. 13. PMID 34944914 DOI: 10.3390/cancers13246293  0.311
2020 Richmond A, Yang J, Yan C, Vilgelm AE, Chen SC, Ayers GD, Johnson CA. Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity. Cancer Immunology Research. PMID 33177110 DOI: 10.1158/2326-6066.CIR-20-0312  0.316
2020 Vilgelm AE, Bergdorf K, Wolf M, Bharti V, Shattuck-Brandt R, Blevins A, Jones C, Phifer C, Lee M, Lowe C, Hongo R, Boyd K, Netterville J, Rohde S, Idrees K, ... ... Richmond A, et al. Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids. Iscience. 23: 101408. PMID 32771978 DOI: 10.1016/J.Isci.2020.101408  0.314
2020 Williams CB, Nebhan CA, Yang J, Starnes LS, Yan C, Vilgelm AE, Chen SC, Dan Ayers G, Abramson V, Mayer IA, Richmond A. Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy. Breast Cancer Research and Treatment. PMID 32767201 DOI: 10.1007/S10549-020-05846-5  0.35
2020 Shattuck-Brandt RL, Chen SC, Murray E, Johnson CA, Crandall H, O'Neal JF, Al-Rohil RN, Nebhan CA, Bharti V, Dahlman KB, Ayers GD, Kelley MC, Kauffman RM, Hooks M, Grau A, ... ... Richmond A, et al. Metastatic Melanoma Patient-derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32234759 DOI: 10.1158/1078-0432.Ccr-19-1895  0.31
2020 Bharti V, Blevins A, Weiss VL, Chen SC, Uzhachenko R, Richmond A, Vilgelm AE. Abstract B20: Patient-derived organoids demonstrate synergistic effect of co-targeting Aurora kinase and prosurvival BCL2 family proteins Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-B20  0.375
2019 Vilgelm AE, Saleh N, Shattuck-Brandt R, Riemenschneider K, Slesur L, Chen SC, Johnson CA, Yang J, Blevins A, Yan C, Johnson DB, Al-Rohil RN, Halilovic E, Kauffmann RM, Kelley M, ... ... Richmond A, et al. MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science Translational Medicine. 11. PMID 31413145 DOI: 10.1126/Scitranslmed.Aav7171  0.318
2019 Vilgelm AE, Richmond A. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy. Frontiers in Immunology. 10: 333. PMID 30873179 DOI: 10.3389/Fimmu.2019.00333  0.399
2019 Blevins A, Mont S, Lawrence H, Saleh N, Chen S, Richmond A, Vilgelm A. Abstract 2552: Senescence induced by CDK4/6 inhibition facilitates anti-tumor T cell responses Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2552  0.327
2019 Yan C, Reddy PE, Richmond A. Abstract 3201: Rigosertib, a Ras mimetic, inhibits melanoma cell viability and synergizes with anti-PD1 to promote anti-tumor immune responses Cancer Research. 79: 3201-3201. DOI: 10.1158/1538-7445.Am2019-3201  0.369
2018 Yang J, Kumar A, Vilgelm AE, Chen SC, Ayers GD, Novitskiy SV, Joyce S, Richmond A. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunology Research. PMID 30108045 DOI: 10.1158/2326-6066.Cir-18-0045  0.436
2018 Rogers M, Sobolik T, Schaffer DK, Samson PC, Johnson AC, Owens P, Codreanu SG, Sherrod SD, McLean JA, Wikswo JP, Richmond A. Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment. Biomicrofluidics. 12: 034102. PMID 29774083 DOI: 10.1063/1.5016433  0.385
2018 Mont S, Black K, Chen S, Ayers GD, Richmond A, Vilgelm AE. Abstract 607: Inhibition of CDK4/6 and Pi3Kγ modulates mammary tumor immune microenvironment to enhance response to immunotherapy Cancer Research. 78: 607-607. DOI: 10.1158/1538-7445.Am2018-607  0.393
2018 Vilgelm AE, Saleh N, Riemenschneider K, Slesur L, Chen S, Ayers GD, Kauffman RM, Kelley MC, Johnson DB, Richmond A. Abstract 4948: MDM2 antagonism overcomes resistance to CDK4/6 inhibition in melanoma Cancer Research. 78: 4948-4948. DOI: 10.1158/1538-7445.Am2018-4948  0.369
2018 Slesur L, Vilgelm A, Al-Rohil R, Richmond A. Abstract B166: Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B166  0.331
2017 Lavender N, Yang J, Chen SC, Sai J, Johnson CA, Owens P, Ayers GD, Richmond A. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo. Bmc Cancer. 17: 88. PMID 28143493 DOI: 10.1186/S12885-017-3074-2  0.358
2017 Vilgelm AE, Johnson CA, Malikayil K, Raman D, Flaherty D, Higgins B, Richmond A. Abstract 513: The link between polyploidy and replication stress in melanoma Cancer Research. 77: 513-513. DOI: 10.1158/1538-7445.Am2017-513  0.321
2016 Pellom ST, Dudimah DF, Thounaojam MC, Uzhachenko RV, Singhal A, Richmond A, Shanker A. Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function. Oncotarget. PMID 28052005 DOI: 10.18632/Oncotarget.14365  0.354
2016 Sai J, Owens P, Novitiskiy SV, Hawkins OE, Vilgelm AE, Yang J, Sobolik-Delmaire T, Lavender N, Johnson AC, McClain C, Ayers GD, Kelley MC, Sanders M, Mayer IA, Moses HL, ... ... Richmond A, et al. PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Anti-tumor Immunity and Anti-PD1 Responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28003307 DOI: 10.1158/1078-0432.Ccr-16-2142  0.342
2016 Saxon JA, Sherrill TP, Polosukhin VV, Sai J, Zaynagetdinov R, McLoed AG, Gulleman PM, Barham W, Cheng DS, Hunt RP, Gleaves LA, Richmond A, Young LR, Yull FE, Blackwell TS. Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment. Oncoimmunology. 5: e1168549. PMID 27471643 DOI: 10.1080/2162402X.2016.1168549  0.39
2016 Vilgelm AE, Johnson DB, Richmond A. Combinatorial approach to cancer immunotherapy: strength in numbers. Journal of Leukocyte Biology. PMID 27256570 DOI: 10.1189/Jlb.5Ri0116-013Rr  0.353
2016 Richmond A, Yang J. The role of NF-kB in modulating antitumor immunity. Oncoimmunology. 5: e1005522. PMID 26942050 DOI: 10.1080/2162402X.2015.1005522  0.352
2016 Sai J, Rogers M, Hockemeyer K, Wikswo JP, Richmond A. Study of Chemotaxis and Cell-Cell Interactions in Cancer with Microfluidic Devices. Methods in Enzymology. 570: 19-45. PMID 26921940 DOI: 10.1016/Bs.Mie.2015.09.023  0.363
2016 Vilgelm AE, Johnson CA, Prasad N, Yang J, Chen SC, Ayers GD, Pawlikowski JS, Raman D, Sosman JA, Kelley M, Ecsedy JA, Shyr Y, Levy SE, Richmond A. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment. Journal of the National Cancer Institute. 108. PMID 26719346 DOI: 10.1093/Jnci/Djv406  0.311
2016 Vilgelm AE, Johnson CA, Prasad N, Yang J, Chen S, Ayers GD, Sosman JA, Ecsedy JA, Yu S, Levy SE, Richmond A. Abstract 5126: The link between therapy-induced senescence and anti-tumor immune microenvironment in melanoma Cancer Research. 76: 5126-5126. DOI: 10.1158/1538-7445.Am2016-5126  0.36
2016 Rogers M, Sobolik T, Schaffer D, Samson P, Wikswo J, Richmond A. Abstract 4268: Examining the 3D tumor microenvironment via microbioreactors Cancer Research. 76: 4268-4268. DOI: 10.1158/1538-7445.Am2016-4268  0.335
2016 Lavender N, Yang J, Sai J, Novitskiy S, Horton L, Johnson A, Abramson V, Mayer I, Meszoely I, Kelley M, Richmond A. Abstract 1410: PI3K inhibitors reduce breast cancer tumor growth and enhance anti-tumor leukocyte activity Cancer Research. 76: 1410-1410. DOI: 10.1158/1538-7445.Am2016-1410  0.367
2015 Su Y, Richmond A. Chemokine Regulation of Neutrophil Infiltration of Skin Wounds. Advances in Wound Care. 4: 631-640. PMID 26543677 DOI: 10.1089/Wound.2014.0559  0.393
2015 Vilgelm A, Richmond A. Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses. Oncoimmunology. 4: e1009299. PMID 26405565 DOI: 10.1080/2162402X.2015.1009299  0.335
2015 Liu Y, Hawkins OE, Vilgelm AE, Pawlikowski JS, Ecsedy JA, Sosman JA, Kelley MC, Richmond A. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152738 DOI: 10.1158/1078-0432.Ccr-15-0293  0.357
2015 Duvall-Noelle N, Karwandyar A, Richmond A, Raman D. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene. PMID 25982273 DOI: 10.1038/Onc.2015.166  0.4
2015 Pawlikowski JS, Brock C, Chen SC, Al-Olabi L, Nixon C, McGregor F, Paine S, Chanudet E, Lambie W, Holmes WM, Mullin JM, Richmond A, Wu H, Blyth K, King A, et al. Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling. The Journal of Investigative Dermatology. 135: 2093-101. PMID 25815427 DOI: 10.1038/Jid.2015.114  0.3
2015 Vilgelm AE, Pawlikowski JS, Liu Y, Hawkins OE, Davis TA, Smith J, Weller KP, Horton LW, McClain CM, Ayers GD, Turner DC, Essaka DC, Stewart CF, Sosman JA, Kelley MC, ... ... Richmond A, et al. Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells. Cancer Research. 75: 181-93. PMID 25398437 DOI: 10.1158/0008-5472.Can-14-2405  0.382
2015 Vilgelm AE, Pawlikowski JS, Liu Y, Oriana EH, Tyler AD, Weller KP, Horton LW, McClain CM, Ayers GD, Turner D, Essaka DC, Stewart CF, Sosman JA, Kelley MC, Ecsedy JA, ... ... Richmond A, et al. Abstract B12: Synergistic anticancer activity of Aurora A kinase and MDM2 antagonists in melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-B12  0.385
2015 Pawlikowski JS, Holmes M, Richmond A. Abstract B11: Manipulating senescence to combat melanoma initiation and progression Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-B11  0.413
2015 Lavender N, Sai J, Yang J, Novitskiy SV, Richmond A. Abstract 422: The role of CCL2 in the breast cancer tumor microenvironment and metastasis Cancer Research. 75: 422-422. DOI: 10.1158/1538-7445.Am2015-422  0.395
2014 Hockemeyer K, Janetopoulos C, Terekhov A, Hofmeister W, Vilgelm A, Costa L, Wikswo JP, Richmond A. Engineered three-dimensional microfluidic device for interrogating cell-cell interactions in the tumor microenvironment. Biomicrofluidics. 8: 044105. PMID 25379090 DOI: 10.1063/1.4890330  0.375
2014 Yang J, Hawkins OE, Barham W, Gilchuk P, Boothby M, Ayers GD, Joyce S, Karin M, Yull FE, Richmond A. Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response. Cancer Research. 74: 7274-84. PMID 25336190 DOI: 10.1158/0008-5472.Can-14-1091  0.416
2014 Raman D, Sai J, Hawkins O, Richmond A. Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration Traffic. 15: 451-469. PMID 24450359 DOI: 10.1111/Tra.12154  0.398
2014 Sobolik T, Su YJ, Wells S, Ayers GD, Cook RS, Richmond A. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways. Molecular Biology of the Cell. 25: 566-82. PMID 24403602 DOI: 10.1091/Mbc.E13-07-0360  0.453
2013 Crowder SW, Horton LW, Lee SH, McClain CM, Hawkins OE, Palmer AM, Bae H, Richmond A, Sung HJ. Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2788-98. PMID 23568779 DOI: 10.1096/Fj.13-228288  0.367
2013 Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM, Kantrow S, Splittgerber RC, Short S, Amiri KI, Ecsedy JA, Sosman JA, Kelley MC, Richmond A. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence Embo Molecular Medicine. 5: 149-166. PMID 23180582 DOI: 10.1002/Emmm.201201378  0.353
2013 Sobolik T, Su Y, Wells S, Richmond A. Abstract A53: CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2, transactivation of HER2/EGFR, and activation of MEK and PI3K pathways Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A53  0.456
2013 Hockemeyer K, Sobolik T, Terekhov A, Swartz M, Hofmeister W, Wikswo J, Janetopoulos C, Richmond A. Abstract 2614: A three-dimensionalin vitrobioreactor for analysis of the tumor microenvironment: investigation of interstitial flow and the mechanism of metastasis. Cancer Research. 73: 2614-2614. DOI: 10.1158/1538-7445.Am2013-2614  0.387
2012 Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. Journal of Immunology (Baltimore, Md. : 1950). 189: 2824-32. PMID 22869904 DOI: 10.4049/Jimmunol.1201114  0.471
2012 Yang J, Kantrow S, Sai J, Hawkins OE, Boothby M, Ayers GD, Young ED, Demicco EG, Lazar AJ, Lev D, Richmond A. INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma. Cancer Research. 72: 4682-95. PMID 22836752 DOI: 10.1158/0008-5472.Can-12-0440  0.323
2012 Su Y, Vilgelm AE, Kelley MC, Hawkins OE, Liu Y, Boyd KL, Kantrow S, Splittgerber RC, Short SP, Sobolik T, Zaja-Milatovic S, Dahlman KB, Amiri KI, Jiang A, Lu P, ... ... Richmond A, et al. RAF265 inhibits the growth of advanced human melanoma tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2184-98. PMID 22351689 DOI: 10.1158/1078-0432.Ccr-11-1122  0.31
2012 Hawkins OE, Richmond A. The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Research : Bcr. 14: 103. PMID 22293321 DOI: 10.1186/Bcr3092  0.367
2012 Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A. NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway. Oncogene. 31: 2580-92. PMID 21963849 DOI: 10.1038/Onc.2011.427  0.324
2012 Vilgelm AE, Liu Y, Levy S, Richmond A. Abstract 5602: Molecular mechanism underlying acquired resistance to Aurora A kinase inhibitor, Alisertib, in melanoma Cancer Research. 72: 5602-5602. DOI: 10.1158/1538-7445.Am2012-5602  0.347
2012 Hawkins OE, Horton L, Fordyce K, Ayers G, Richmond A. Abstract 4403: Combined antagonism of the IL-4R and IKKα inhibits melanoma tumor growth in immunocompetent mice Cancer Research. 72: 4403-4403. DOI: 10.1158/1538-7445.Am2012-4403  0.372
2012 Raman D, Duvall-Noelle N, Richmond A. Abstract P1-05-01: Chemokine-mediated nuclear translocation and novel nuclear role for LIM and SH3 Protein-1(LASP-1) in breast cancer Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-05-01  0.482
2011 Neel NF, Sai J, Ham AJ, Sobolik-Delmaire T, Mernaugh RL, Richmond A. IQGAP1 is a novel CXCR2-interacting protein and essential component of the "chemosynapse". Plos One. 6: e23813. PMID 21876773 DOI: 10.1371/Journal.Pone.0023813  0.784
2011 Raman D, Milatovic SZ, Milatovic D, Splittgerber R, Fan GH, Richmond A. Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity. Toxicology and Applied Pharmacology. 256: 300-13. PMID 21704645 DOI: 10.1016/J.Taap.2011.06.006  0.31
2011 Richmond A. Chemokine research moves on. Experimental Cell Research. 317: 553-5. PMID 21241691 DOI: 10.1016/J.Yexcr.2011.01.016  0.318
2011 Raman D, Sobolik-Delmaire T, Richmond A. Chemokines in health and disease. Experimental Cell Research. 317: 575-89. PMID 21223965 DOI: 10.1016/J.Yexcr.2011.01.005  0.375
2011 Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, ... ... Richmond A, et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Research. 71: 603-13. PMID 21123450 DOI: 10.1158/0008-5472.Can-10-3185  0.769
2010 Thu YM, Richmond A. NF-κB inducing kinase: a key regulator in the immune system and in cancer. Cytokine & Growth Factor Reviews. 21: 213-26. PMID 20685151 DOI: 10.1016/J.Cytogfr.2010.06.002  0.387
2010 Das ST, Rajagopalan L, Guerrero-Plata A, Sai J, Richmond A, Garofalo RP, Rajarathnam K. Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. Plos One. 5: e11754. PMID 20668677 DOI: 10.1371/Journal.Pone.0011754  0.376
2010 Gruver JS, Potdar AA, Jeon J, Sai J, Anderson B, Webb D, Richmond A, Quaranta V, Cummings PT, Chung CY. Bimodal analysis reveals a general scaling law governing nondirected and chemotactic cell motility. Biophysical Journal. 99: 367-76. PMID 20643054 DOI: 10.1016/J.Bpj.2010.03.073  0.322
2010 Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A. Conditional ablation of Ikkb inhibits melanoma tumor development in mice. The Journal of Clinical Investigation. 120: 2563-74. PMID 20530876 DOI: 10.1172/Jci42358  0.397
2010 Raman D, Sai J, Neel NF, Chew CS, Richmond A. LIM and SH3 protein-1 modulates CXCR2-mediated cell migration. Plos One. 5: e10050. PMID 20419088 DOI: 10.1371/Journal.Pone.0010050  0.778
2010 Richmond A. Chemokine modulation of the tumor microenvironment. Pigment Cell & Melanoma Research. 23: 312-3. PMID 20415714 DOI: 10.1111/J.1755-148X.2010.00714.X  0.39
2010 Lazennec G, Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends in Molecular Medicine. 16: 133-44. PMID 20163989 DOI: 10.1016/J.Molmed.2010.01.003  0.452
2010 Su Y, Amiri KI, Horton LW, Yu Y, Ayers GD, Koehler E, Kelley MC, Puzanov I, Richmond A, Sosman JA. A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 348-57. PMID 20028756 DOI: 10.1158/1078-0432.Ccr-09-2087  0.301
2009 Yang J, Richmond AJ. Monitoring NF-kappaB mediated chemokine transcription in tumorigenesis. Methods in Enzymology. 460: 347-55. PMID 19446734 DOI: 10.1016/S0076-6879(09)05217-3  0.302
2009 Raman D, Neel NF, Sai J, Mernaugh RL, Ham AJ, Richmond AJ. Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse". Methods in Enzymology. 460: 315-30. PMID 19446732 DOI: 10.1016/S0076-6879(09)05215-X  0.765
2009 Neel NF, Barzik M, Raman D, Sobolik-Delmaire T, Sai J, Ham AJ, Mernaugh RL, Gertler FB, Richmond A. VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. Journal of Cell Science. 122: 1882-94. PMID 19435808 DOI: 10.1242/Jcs.039057  0.782
2009 Yang J, Zaja-Milatovic S, Thu YM, Lee F, Smykla R, Richmond A. Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. Molecular Cancer Therapeutics. 8: 636-47. PMID 19276165 DOI: 10.1158/1535-7163.Mct-08-0749  0.391
2009 Richmond A, Yang J, Su Y. The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell & Melanoma Research. 22: 175-86. PMID 19222802 DOI: 10.1111/J.1755-148X.2009.00554.X  0.495
2009 Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, Graham GJ, Segerer S, Nibbs RJ, Rot A. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nature Immunology. 10: 101-8. PMID 19060902 DOI: 10.1038/Ni.1675  0.469
2008 Richmond A, Su Y. Mouse xenograft models vs GEM models for human cancer therapeutics. Disease Models & Mechanisms. 1: 78-82. PMID 19048064 DOI: 10.1242/Dmm.000976  0.308
2008 Zaja-Milatovic S, Richmond A. CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histology and Histopathology. 23: 1399-407. PMID 18785122 DOI: 10.14670/Hh-23.1399  0.371
2008 Baugher PJ, Richmond A. The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis. The Journal of Biological Chemistry. 283: 30868-78. PMID 18755694 DOI: 10.1074/Jbc.M804054200  0.415
2008 Sai J, Raman D, Liu Y, Wikswo J, Richmond A. Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis. The Journal of Biological Chemistry. 283: 26538-47. PMID 18662984 DOI: 10.1074/Jbc.M805611200  0.397
2008 Yu Y, Su Y, Opalenik SR, Sobolik-Delmaire T, Neel NF, Zaja-Milatovic S, Short ST, Sai J, Richmond A. Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2. Journal of Leukocyte Biology. 84: 406-19. PMID 18505935 DOI: 10.1189/Jlb.0807544  0.743
2008 Dhawan P, Su Y, Thu YM, Yu Y, Baugher P, Ellis DL, Sobolik-Delmaire T, Kelley M, Cheung TC, Ware CF, Richmond A. The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. The Journal of Biological Chemistry. 283: 15399-408. PMID 18347013 DOI: 10.1074/Jbc.M708272200  0.388
2008 Richmond A. CCR9 homes metastatic melanoma cells to the small bowel. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 621-3. PMID 18245518 DOI: 10.1158/1078-0432.Ccr-07-2235  0.337
2008 Liu Y, Sai J, Richmond A, Wikswo JP. Microfluidic switching system for analyzing chemotaxis responses of wortmannin-inhibited HL-60 cells. Biomedical Microdevices. 10: 499-507. PMID 18205049 DOI: 10.1007/S10544-007-9158-Z  0.358
2008 Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC, Moses HL. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 13: 23-35. PMID 18167337 DOI: 10.1016/J.Ccr.2007.12.004  0.416
2007 Horton LW, Yu Y, Zaja-Milatovic S, Strieter RM, Richmond A. Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Research. 67: 9791-9. PMID 17942909 DOI: 10.1158/0008-5472.Can-07-0246  0.458
2007 Kantrow SM, Boyd AS, Ellis DL, Nanney LB, Richmond A, Shyr Y, Robbins JB. Expression of activated Akt in benign nevi, Spitz nevi and melanomas. Journal of Cutaneous Pathology. 34: 593-6. PMID 17640227 DOI: 10.1111/J.1600-0560.2006.00675.X  0.379
2007 Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Letters. 256: 137-65. PMID 17629396 DOI: 10.1016/J.Canlet.2007.05.013  0.445
2007 Schutyser E, Su Y, Yu Y, Gouwy M, Zaja-Milatovic S, Van Damme J, Richmond A. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. European Cytokine Network. 18: 59-70. PMID 17594938 DOI: 10.1684/Ecn.2007.0087  0.433
2007 Ueda Y, Su Y, Richmond A. CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells. Melanoma Research. 17: 91-103. PMID 17496784 DOI: 10.1097/Cmr.0B013E3280A60888  0.415
2007 Miller-Kittrell M, Sai J, Penfold M, Richmond A, Sparer TE. Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV). Virology. 364: 454-65. PMID 17433398 DOI: 10.1016/J.Virol.2007.03.002  0.369
2007 Yang J, Pan WH, Clawson GA, Richmond A. Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Cancer Research. 67: 3127-34. PMID 17409419 DOI: 10.1158/0008-5472.Can-06-3547  0.377
2007 Neel NF, Lapierre LA, Goldenring JR, Richmond A. RhoB plays an essential role in CXCR2 sorting decisions. Journal of Cell Science. 120: 1559-71. PMID 17405813 DOI: 10.1242/Jcs.03437  0.785
2007 Yang J, Su Y, Richmond A. Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway. Free Radical Biology & Medicine. 42: 1369-80. PMID 17395010 DOI: 10.1016/J.Freeradbiomed.2007.01.036  0.345
2006 Lee JS, Wurfel MM, Matute-Bello G, Frevert CW, Rosengart MR, Ranganathan M, Wong VW, Holden T, Sutlief S, Richmond A, Peiper S, Martin TR. The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. Journal of Immunology (Baltimore, Md. : 1950). 177: 8086-94. PMID 17114483 DOI: 10.4049/Jimmunol.177.11.8086  0.332
2006 Sai J, Walker G, Wikswo J, Richmond A. The IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells. The Journal of Biological Chemistry. 281: 35931-41. PMID 16990258 DOI: 10.1074/Jbc.M605883200  0.43
2006 Amiri KI, Ha HC, Smulson ME, Richmond A. Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1. Oncogene. 25: 7714-22. PMID 16799643 DOI: 10.1038/Sj.Onc.1209751  0.426
2006 Ueda Y, Neel NF, Schutyser E, Raman D, Richmond A. Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Research. 66: 5665-75. PMID 16740704 DOI: 10.1158/0008-5472.Can-05-3579  0.794
2006 Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK, DuBois RN. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. The Journal of Experimental Medicine. 203: 941-51. PMID 16567391 DOI: 10.1084/Jem.20052124  0.416
2006 Ueda Y, Richmond A. NF-kappaB activation in melanoma. Pigment Cell Research / Sponsored by the European Society For Pigment Cell Research and the International Pigment Cell Society. 19: 112-24. PMID 16524427 DOI: 10.1111/J.1600-0749.2006.00304.X  0.32
2006 Yang J, Amiri KI, Burke JR, Schmid JA, Richmond A. BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 950-60. PMID 16467110 DOI: 10.1158/1078-0432.Ccr-05-1220  0.387
2005 Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A. Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models. Journal of Immunology (Baltimore, Md. : 1950). 175: 5396-402. PMID 16210646 DOI: 10.4049/Jimmunol.175.8.5396  0.422
2005 Neel NF, Schutyser E, Sai J, Fan GH, Richmond A. Chemokine receptor internalization and intracellular trafficking. Cytokine & Growth Factor Reviews. 16: 637-58. PMID 15998596 DOI: 10.1016/J.Cytogfr.2005.05.008  0.761
2005 Amiri KI, Richmond A. Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Reviews. 24: 301-13. PMID 15986139 DOI: 10.1007/S10555-005-1579-7  0.334
2005 Walker GM, Sai J, Richmond A, Stremler M, Chung CY, Wikswo JP. Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator. Lab On a Chip. 5: 611-8. PMID 15915253 DOI: 10.1039/B417245K  0.326
2005 Schutyser E, Richmond A, Van Damme J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. Journal of Leukocyte Biology. 78: 14-26. PMID 15784687 DOI: 10.1189/Jlb.1204712  0.392
2004 Sai J, Fan GH, Wang D, Richmond A. The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis. Journal of Cell Science. 117: 5489-96. PMID 15479720 DOI: 10.1242/Jcs.01398  0.452
2004 Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Research. 64: 4912-8. PMID 15256463 DOI: 10.1158/0008-5472.Can-04-0673  0.383
2004 Yang J, Richmond A. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 846-55. PMID 15194051 DOI: 10.1016/J.Ymthe.2004.01.010  0.432
2004 Richmond A, Fan GH, Dhawan P, Yang J. How do chemokine/chemokine receptor activations affect tumorigenesis? Novartis Foundation Symposium. 256: 74-89; discussion 89. PMID 15027484 DOI: 10.1002/0470856734.Ch6  0.45
2004 Fan GH, Lapierre LA, Goldenring JR, Sai J, Richmond A. Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis. Molecular Biology of the Cell. 15: 2456-69. PMID 15004234 DOI: 10.1091/Mbc.E03-09-0706  0.462
2003 Amiri KI, Richmond A. Fine tuning the transcriptional regulation of the CXCL1 chemokine. Progress in Nucleic Acid Research and Molecular Biology. 74: 1-36. PMID 14510072 DOI: 10.1016/S0079-6603(03)01009-2  0.391
2003 Milatovic S, Nanney LB, Yu Y, White JR, Richmond A. Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 11: 213-9. PMID 12753603 DOI: 10.1046/J.1524-475X.2003.11310.X  0.332
2003 Wang D, Sai J, Richmond A. Cell surface heparan sulfate participates in CXCL1-induced signaling. Biochemistry. 42: 1071-7. PMID 12549928 DOI: 10.1021/Bi026425A  0.467
2003 Fan GH, Lapierre LA, Goldenring JR, Richmond A. Differential regulation of CXCR2 trafficking by Rab GTPases. Blood. 101: 2115-24. PMID 12411301 DOI: 10.1182/Blood-2002-07-1965  0.457
2002 Richmond A. Nf-kappa B, chemokine gene transcription and tumour growth. Nature Reviews. Immunology. 2: 664-74. PMID 12209135 DOI: 10.1038/Nri887  0.308
2002 Dhawan P, Richmond A. Role of CXCL1 in tumorigenesis of melanoma. Journal of Leukocyte Biology. 72: 9-18. PMID 12101257 DOI: 10.1189/Jlb.72.1.9  0.452
2002 Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E, Richmond A. PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry. 41: 7100-7. PMID 12033944 DOI: 10.1021/Bi025902M  0.409
2002 Du J, Luan J, Liu H, Daniel TO, Peiper S, Chen TS, Yu Y, Horton LW, Nanney LB, Strieter RM, Richmond A. Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. Journal of Leukocyte Biology. 71: 141-53. PMID 11781390 DOI: 10.1189/Jlb.71.1.141  0.427
2002 Dhawan P, Richmond A. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. The Journal of Biological Chemistry. 277: 7920-8. PMID 11773061 DOI: 10.1074/Jbc.M112210200  0.364
2002 Fan GH, Yang W, Sai J, Richmond A. Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking. The Journal of Biological Chemistry. 277: 6590-7. PMID 11751889 DOI: 10.1074/Jbc.M110588200  0.445
2001 Yang J, Fan GH, Wadzinski BE, Sakurai H, Richmond A. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. The Journal of Biological Chemistry. 276: 47828-33. PMID 11591705 DOI: 10.1074/Jbc.M106103200  0.377
2001 Luan J, Furuta Y, Du J, Richmond A. Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. Cytokine. 14: 253-263. PMID 11444905 DOI: 10.1006/Cyto.2001.0882  0.409
2001 Nirodi C, Hart J, Dhawan P, Moon NS, Nepveu A, Richmond A. The role of CDP in the negative regulation of CXCL1 gene expression. The Journal of Biological Chemistry. 276: 26122-31. PMID 11371564 DOI: 10.1074/Jbc.M102872200  0.356
2001 Fan GH, Yang W, Sai J, Richmond A. Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme. The Journal of Biological Chemistry. 276: 16960-8. PMID 11278485 DOI: 10.1074/Jbc.M009292200  0.433
2001 Fan GH, Yang W, Wang XJ, Qian Q, Richmond A. Identification of a motif in the carboxyl terminus of CXCR2 that is involved in adaptin 2 binding and receptor internalization. Biochemistry. 40: 791-800. PMID 11170396 DOI: 10.1021/Bi001661B  0.457
2001 Nirodi CS, Devalaraja R, Nanney LB, Arrindell S, Russell S, Trupin J, Richmond A. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 8: 371-82. PMID 11115149 DOI: 10.1111/J.1524-475X.2000.00371.X  0.412
2000 Nirodi C, NagDas S, Gygi SP, Olson G, Aebersold R, Richmond A. A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. The Journal of Biological Chemistry. 276: 9366-74. PMID 11112786 DOI: 10.1074/Jbc.M009897200  0.355
2000 Wang D, Richmond A. Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway. The Journal of Biological Chemistry. 276: 3650-9. PMID 11062239 DOI: 10.1074/Jbc.M006115200  0.357
2000 Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. Journal of Immunology (Baltimore, Md. : 1950). 165: 5269-77. PMID 11046061 DOI: 10.4049/Jimmunol.165.9.5269  0.479
2000 Wang D, Yang W, Du J, Devalaraja MN, Liang P, Matsumoto K, Tsubakimoto K, Endo T, Richmond A. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene. 19: 4647-59. PMID 11030154 DOI: 10.1038/Sj.Onc.1203820  0.304
2000 Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A. Delayed wound healing in CXCR2 knockout mice. The Journal of Investigative Dermatology. 115: 234-44. PMID 10951241 DOI: 10.1046/J.1523-1747.2000.00034.X  0.355
2000 Richmond A, Kaempfer R. Cytokines revisited at Hilton Head Cytokine & Growth Factor Reviews. 11: 255-266. PMID 10817967 DOI: 10.1016/S1359-6101(00)00008-3  0.35
2000 Haghnegahdar H, Du J, Wang D, Strieter RM, Burdick MD, Nanney LB, Cardwell N, Luan J, Shattuck-Brandt R, Richmond A. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. Journal of Leukocyte Biology. 67: 53-62. PMID 10647998 DOI: 10.1002/Jlb.67.1.53  0.419
1999 Devalaraja MN, Richmond A. Multiple chemotactic factors: fine control or redundancy? Trends in Pharmacological Sciences. 20: 151-156. PMID 10322500 DOI: 10.1016/S0165-6147(99)01342-5  0.421
1999 Yang W, Wang D, Richmond A. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. Journal of Biological Chemistry. 274: 11328-11333. PMID 10196223 DOI: 10.1074/Jbc.274.16.11328  0.491
1998 Tang T, Owen JD, Du J, Walker CL, Richmond A. Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines Mitochondrial Dna. 9: 129-143. PMID 10520743 DOI: 10.3109/10425179809072188  0.344
1998 Nanney LB, Skeel A, Luan J, Polis S, Richmond A, Wang MH, Leonard EJ. Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury. The Journal of Investigative Dermatology. 111: 573-81. PMID 9764835 DOI: 10.1046/J.1523-1747.1998.00332.X  0.403
1997 Yang W, Schraw WP, Mueller SG, Richmond A. Interruption of g protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPγ35S binding, calcium mobilization, and chemotaxis Biochemistry. 36: 15193-15200. PMID 9398246 DOI: 10.1021/Bi971594U  0.4
1997 Luan J, Shattuck-Brandt R, Haghnegahdar H, Owen JD, Strieter R, Burdick M, Nirodi C, Beauchamp D, Johnson KN, Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. Journal of Leukocyte Biology. 62: 588-97. PMID 9365113 DOI: 10.1002/Jlb.62.5.588  0.401
1997 Richmond A, Mueller S, White JR, Schraw W. C-X-C chemokine receptor desensitization mediated through ligand-enhanced receptor phosphorylation on serine residues. Methods in Enzymology. 288: 3-15. PMID 9356983 DOI: 10.1016/S0076-6879(97)88003-2  0.353
1997 Owen JD, Strieter R, Burdick M, Haghnegahdar H, Nanney L, Shattuck-Brandt R, Richmond A. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. International Journal of Cancer. 73: 94-103. PMID 9334815 DOI: 10.1002/(Sici)1097-0215(19970926)73:1<94::Aid-Ijc15>3.0.Co;2-5  0.352
1997 Mueller SG, White JR, Schraw WP, Lam V, Richmond A. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor Journal of Biological Chemistry. 272: 8207-8214. PMID 9079638 DOI: 10.1074/Jbc.272.13.8207  0.414
1996 Wood LD, Richmond A. Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors. The Journal of Biological Chemistry. 270: 30619-26. PMID 8530498 DOI: 10.1074/Jbc.270.51.30619  0.355
1995 Mueller SG, Schraw WP, Richmond A. Activation of protein kinase C enhances the phosphorylation of the type B interleukin-8 receptor and stimulates its degradation in non-hematopoietic cells Journal of Biological Chemistry. 270: 10439-10448. PMID 7737978 DOI: 10.1074/Jbc.270.18.10439  0.434
1995 Schraw W, Richmond A. Melanoma growth stimulatory activity signaling through the class II interleukin-8 receptor enhances the tyrosine phosphorylation of Crk-associated substrate, p130, and a 70-kilodalton protein Biochemistry. 34: 13760-13767. PMID 7577968 DOI: 10.1021/Bi00042A006  0.378
1995 Wood LD, Farmer AA, Richmond A. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Research. 23: 4210-9. PMID 7479086 DOI: 10.1093/Nar/23.20.4210  0.311
1994 Shattuck RL, Wood LD, Jaffe GJ, Richmond A. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Molecular and Cellular Biology. 14: 791-802. PMID 8264646 DOI: 10.1128/mcb.14.1.791-802.1994  0.305
1993 Tettelbach W, Nanney L, Ellis D, King L, Richmond A. Localization of MGSA/GRO protein in cutaneous lesions. Journal of Cutaneous Pathology. 20: 259-66. PMID 8366215 DOI: 10.1111/J.1600-0560.1993.Tb00653.X  0.307
1990 Bordoni R, Fine R, Murray D, Richmond A. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes Journal of Cellular Biochemistry. 44: 207-219. PMID 2095366 DOI: 10.1002/Jcb.240440403  0.345
1989 Bordoni R, Thomas G, Richmond A. Growth factor modulation of melanoma growth stimulatory activity mRNA expression in human malignant melanoma cells correlates with cell growth. Journal of Cellular Biochemistry. 39: 421-8. PMID 2722970 DOI: 10.1002/Jcb.240390408  0.36
1988 Richmond A, Thomas HG, Roy RG. Separation of melanoma growth stimulatory activity and human type-alpha transforming growth factor. Methods in Enzymology. 146: 112-26. PMID 3479673 DOI: 10.1016/S0076-6879(87)46014-X  0.35
1988 Richmond A, Thomas HG. Melanoma growth stimulatory activity: Isolation from human melanoma tumors and characterization of tissue distribution Journal of Cellular Biochemistry. 36: 185-198. PMID 3356754 DOI: 10.1002/Jcb.240360209  0.332
1988 Thomas HG, Richmond A. Immunoaffinity purification of melanoma growth stimulatory activity. Archives of Biochemistry and Biophysics. 260: 719-724. PMID 3341763 DOI: 10.1016/0003-9861(88)90501-2  0.324
1988 Richmond A, Balentien E, Thomas HG, Flaggs G, Barton DE, Spiess J, Bordoni R, Francke U, Derynck R. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. The Embo Journal. 7: 2025-33. PMID 2970963 DOI: 10.1002/J.1460-2075.1988.Tb03042.X  0.325
1987 Lawson DH, Thomas HG, Roy RGB, Gordon DS, Chawla RK, Nixon DW, Richmond A. Preparation of a monoclonal antibody to a melanoma growth‐stimulatory activity released into serum‐free culture medium by Hs0294 malignant melanoma cells Journal of Cellular Biochemistry. 34: 169-185. PMID 3611199 DOI: 10.1002/Jcb.240340304  0.301
1986 Richmond A, Thomas HG. Purification of melanoma growth stimulatory activity. Journal of Cellular Physiology. 129: 375-384. PMID 3465735 DOI: 10.1002/Jcp.1041290316  0.314
Show low-probability matches.